Intravesical Chemotherapy-Reference-Cited by-同舟云学术

Intravesical Chemotherapy

Published:2018 Issue: Volume: Page:263-276
ISSN:
Container-title:Bladder Cancer
language:
Short-container-title:

Author:

Kim Sun Il,Choo Seol Ho

Publisher

Elsevier

Reference72 articles.

1. Severe pancytopenia associated with the use of intravesical thio-TEPA;Watkins;J Urol,1967

2. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder;Koontz;J Urol,1981

3. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer—intravesical thio-TEPA versus oral UFT;Hirao;Cancer Chemother Pharmacol,1992

4. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer. Br J Urol 1994;73(6):632–8.

5. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group;Akaza;Cancer Chemother Pharmacol,1987

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder;Science Robotics;2021-03-17

2. Monitoring the collective behavior of enzymatic nanomotors in vitro and in vivo by PET-CT;2020-06-23

3. RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy;BMC Urology;2019-07-24